Search research articles
Contact Us
Filters
Showing results (471-480 of 945) with videos related to
Page
of 95
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 1, 1992
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones
H S Sader, M E Erwin, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 1, 1984
The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci
R N Jones, A L Barry, R R Packer
Journal of Chemotherapy (Florence, Italy)
|
March 18, 2008
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
A C Galles, R N Jones, H S Sader
Diagnostic Microbiology and Infectious Disease
|
September 1, 1994
Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals
S P Murphy, M E Erwin, R N Jones
Journal of Clinical Microbiology
|
November 1, 1992
Use of the E test to predict high-level resistance to aminoglycosides among enterococci
M L Sanchez, M S Barrett, R N Jones
Journal of Clinical Microbiology
|
July 10, 2004
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used
T R Anderegg, R N Jones, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1992
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin
W W Hoover, M S Barrett, R N Jones
Diagnostic Microbiology and Infectious Disease
|
November 1, 1991
Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella
R N Jones, M E Erwin, M S Barrett
Diagnostic Microbiology and Infectious Disease
|
February 1, 1993
Species identification and determination of high-level aminoglycoside resistance among enterococci. Comparison study of sterile body fluid isolates, 1985-1991
B J Buschelman, M J Bale, R N Jones
Irish Journal of Medical Science
|
October 1, 1995
Comparative antimicrobial activity and spectrum of CP-99,219, a novel fluoroquinolone, tested against ciprofloxacin-resistant clinical isolates
S P Murphy, M G Cormican, R N Jones
Page
of 95
Search research articles
Search
Showing results (471-480 of 945) with videos related to
Sort By:
Page
of 95
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
April 1, 1992
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones
H S Sader, M E Erwin, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 1, 1984
The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci
R N Jones, A L Barry, R R Packer
Journal of Chemotherapy (Florence, Italy)
|
March 18, 2008
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
A C Galles, R N Jones, H S Sader
Diagnostic Microbiology and Infectious Disease
|
September 1, 1994
Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals
S P Murphy, M E Erwin, R N Jones
Journal of Clinical Microbiology
|
November 1, 1992
Use of the E test to predict high-level resistance to aminoglycosides among enterococci
M L Sanchez, M S Barrett, R N Jones
Journal of Clinical Microbiology
|
July 10, 2004
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used
T R Anderegg, R N Jones, H S Sader, et al.
Diagnostic Microbiology and Infectious Disease
|
March 1, 1992
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin
W W Hoover, M S Barrett, R N Jones
Diagnostic Microbiology and Infectious Disease
|
November 1, 1991
Antimicrobial activity of three investigational oral cephalosporins (BK-218, cefdinir, and RU29246) against Legionella
R N Jones, M E Erwin, M S Barrett
Diagnostic Microbiology and Infectious Disease
|
February 1, 1993
Species identification and determination of high-level aminoglycoside resistance among enterococci. Comparison study of sterile body fluid isolates, 1985-1991
B J Buschelman, M J Bale, R N Jones
Irish Journal of Medical Science
|
October 1, 1995
Comparative antimicrobial activity and spectrum of CP-99,219, a novel fluoroquinolone, tested against ciprofloxacin-resistant clinical isolates
S P Murphy, M G Cormican, R N Jones
Page
of 95